Physician
Niebles and Samter MDS P.A
Niebles and Samter MDS P.A was paid $2.43M by Medicaid between Jan 2019 and Dec 2024, across 56 billing codes. Its largest line is 99214, doctor's office visit, returning patient (more involved) — 27% of everything it billed.
33Billing provider infoNIEBLES AND SAMTER MDS P.A
TAMPA, FL 33612
TAMPA, FL 33612
33aNPI1568500635assigned 02/02/2007
33bProvider typePediatrics Physician
28Total paid$2.43M
24GClaims85,697
24DCodes billed56
24AFirst – last monthJan 2019 – Dec 2024
Compared with peers
Next to other Pediatrics Physician providers in Florida
Rank by total paid#134 of 971
Median peer was paid$238K
This provider vs. median10×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2019 | 17,208 | $452K | |
| 2020 | 14,051 | $420K | |
| 2021 | 15,234 | $451K | |
| 2022 | 16,875 | $512K | |
| 2023 | 15,858 | $420K | |
| 2024incomplete | 6,471 | $172K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 27% | 9,592 | 8,982 | $644K |
| 99393 | Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) | 16% | 3,427 | 3,364 | $386K |
| 99392 | Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) | 15% | 3,240 | 3,171 | $366K |
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 12% | 8,001 | 7,466 | $282K |
| 99394 | Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) | 10% | 2,146 | 2,116 | $253K |
| 99391 | Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) | 8.4% | 1,997 | 1,902 | $203K |
| 97802 | 2.5% | 7,308 | 7,167 | $61K | |
| 90460 | Immunization administration through 18 years of age via any route, first or only component | 2.2% | 6,944 | 6,791 | $53K |
| 92283 | 2.0% | 7,132 | 6,990 | $48K | |
| 99188 | <1% | 3,113 | 3,041 | $17K | |
| 87811 | Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) | <1% | 1,142 | 1,067 | $14K |
| 90670 | <1% | 1,760 | 1,730 | $13K |
44 more codes
| 99381 | <1% | 146 | $12K | |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | <1% | 1,037 | $8K |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | <1% | 220 | $7K |
| 99050 | <1% | 1,055 | $5K | |
| 90700 | <1% | 317 | $4K | |
| 90698 | <1% | 215 | $4K | |
| 99383 | <1% | 31 | $4K | |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | <1% | 850 | $4K |
| 87807 | <1% | 366 | $4K | |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | <1% | 730 | $4K |
| 90723 | <1% | 875 | $3K | |
| 99395 | Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years | <1% | 27 | $3K |
| 90686 | <1% | 824 | $3K | |
| 90734 | <1% | 924 | $2K | |
| 90633 | <1% | 1,060 | $2K | |
| 85018 | <1% | 1,711 | $2K | |
| 90707 | <1% | 446 | $2K | |
| 94664 | <1% | 612 | $2K | |
| 90744 | <1% | 131 | $2K | |
| 90651 | <1% | 932 | $2K | |
| 90715 | <1% | 383 | $2K | |
| 85014 | <1% | 1,611 | $1K | |
| G0447 | Face-to-face behavioral counseling for obesity, 15 minutes | <1% | 8,436 | $1K |
| 99051 | <1% | 437 | $818.01 | |
| A7003 | Administration set, with small volume nonfiltered pneumatic nebulizer, disposable | <1% | 564 | $675.62 |
| 90648 | <1% | 295 | $578.91 | |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 147 | $559.66 |
| 90716 | <1% | 429 | $316.41 | |
| 96110 | Developmental screening, with scoring and documentation, per standardized instrument | <1% | 44 | $269.10 |
| 90696 | <1% | 227 | $251.12 | |
| 92551 | <1% | 1,253 | $193.50 | |
| 81002 | <1% | 151 | $166.58 | |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | <1% | 44 | $158.15 |
| 90620 | <1% | 64 | $136.24 | |
| 90647 | <1% | 753 | $102.66 | |
| 90713 | <1% | 75 | $49.15 | |
| 90685 | <1% | 18 | $28.87 | |
| 94760 | <1% | 657 | $4.94 | |
| J7613 | Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 1 mg | <1% | 710 | $2.64 |
| G8510 | Screening for depression is documented as negative, a follow-up plan is not required | 0% | 101 | $0.00 |
| 96127 | 0% | 400 | $0.00 | |
| 99000 | 0% | 12 | $0.00 | |
| 90710 | 0% | 246 | $0.00 | |
| 90681 | 0% | 329 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialNIEBLES, JACQUELINE (PRESIDENT)
| Provider | Location | Paid |
|---|---|---|
| The Childrens Doctor of Tampabay, Jacquelin Eniebles MD, PLLC | Tampa, FL | $680K |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.